Sadhana Nitro Chem announced that the company has received approval for its application under Production Linked Incentive (PLI) Scheme from IFCI no behalf of the Department of Pharmaceuticals for the production of Para Amino Phenol (PAP) and is under the segment Key Chemical Synthesis Based KSMs/Drug Intermediates.
Additionally, due to the present pandemic situation, while the installation of the PAP plant continues to be ongoing, there have been resultant delays pushing the commercial launch date.
The first phase of the plant is expected to go live in July, 2021 and second phase in August, 2021.
Powered by Capital Market - Live News
Sadhana Nitro Chem Limited updates on Para Amino Phenol (PAP) plant equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs has received an approval accorded under Production Linked Incentive (PLI) scheme for pharmaceutical sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs 6,940 crore.
The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country. The tenure of the scheme is from FY21 to FY30.
Moderate gains seen at open, but crude, FPI flow to anchor direction
March 08, 2021
×
Asian markets in early trade on Monday are up 0.5-1.5%; US markets on Friday closed up 1.55-2%; analysts fear the market may see volatility
The Indian stock markets, after falling a couple of days, are expected to open on a positive note on Monday, thanks to global markets. The SGX Nifty, ruling at 15,080, points to a 130-point gain for Nifty futures, which on Friday closed at 14,953 on the NSE.
Asian markets in early trade on Monday are up in the range of between 0.5 and 1.5 per cent. Australian indices are ruling with the biggest gains on Monday, while China, Japan and Taiwan too are firm. The US markets on Friday too closed up 1.55-2 per cent.
Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector.
Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-reliance and reducing import dependence in these critical Key Starting Materials (KSMs)/ Drug Intermediates/ Active Pharmaceutical Ingredients (APIs) in the country.